Preventive Medicine 2018
Journal of Preventive Medicine
ISSN: 2572-5483
Page 71
July 16-17, 2018
London, UK
9
th
Edition of International Conference on
Preventive Medicine
& Public Health
C
ombination vaccines have been extensively used for decades
and bring together the issue of intersection-union. To make
up for the reduction in statistical power at the study level,
researchers have to increase the study sample size. In view of
the nature of immunogenicity variables, we use the geometric
mean concentration of immune response after vaccination as
immunologic endpoint and compare three sample size calculation
methods: the inflation factors method, the incrementing method
and the Bonferroni correction method when there are multiple
continuous co-primary endpoints. The parameters are set
according to the actual situation of combination vaccines and
the simulation results were used as reference. The present study
demonstrates that the incrementing method, the Bonferroni
corrected method and the inflation factors method are all
available when the effect size of each endpoint is comparable
and there is no or weak correlation between each endpoint. When
there is a valid difference of effect sizes among endpoints, the
incrementing method performs better.
yang_jy@foxmail.comComparison of three sample size estimation methods for non-
inferiority vaccine trials with multiple continuous co-primary
endpoints
Jiaying Yang
1
, Jingxin Li, Shiyuan Wang, Li Luo
and
Pei Liu
1
Southeast University, China
J Prev Med 2018, Volume 3
DOI: 10.21767/2572-5483-C1-003